|
Volumn 4, Issue 4, 2013, Pages 471-477
|
Critical challenges to the design of drug-eluting medical devices
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYPHER;
DEXAMETHASONE;
ESTRADIOL;
EVEROLIMUS;
INSULIN;
PACLITAXEL;
PIMECROLIMUS;
POLYGLACTIN;
RAPAMYCIN;
UNCLASSIFIED DRUG;
BIOCOMPATIBILITY;
CONTROLLED RELEASE FORMULATION;
DEVICE SAFETY;
DIABETES MELLITUS;
DRUG COATING;
DRUG DELIVERY DEVICE;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG ELUTING STENT;
DRUG PACKAGING;
DRUG POTENCY;
DRUG SAFETY;
DRUG STABILITY;
EQUIPMENT DESIGN;
EXCIPIENT COMPATIBILITY;
HUMAN;
IN-STENT RESTENOSIS;
INSULIN PUMP;
NONHUMAN;
PRIORITY JOURNAL;
PROCESS DEVELOPMENT;
PRODUCT DEVELOPMENT;
REVIEW;
RISK ASSESSMENT;
SHELF LIFE;
|
EID: 84875948052
PISSN: 20415990
EISSN: 20416008
Source Type: Journal
DOI: 10.4155/tde.13.17 Document Type: Review |
Times cited : (9)
|
References (16)
|